Chantix Ad Gains Recognition At Doctors' Choice Awards
Date: 21st September 2007
A survey headed by 6,040 doctors involved 332 professional advertisements in 11 therapeutic categories and the results of the survey declared a 2 page chantix ad, launched by Euro RSCG Life LM&P as the top advertisement in the general practice category and a one page long NuvaRing ad created by CommonHealth's Adient as the topmost ad in the specialty category. These results were announced by physicians at the fifth annual Doctors' Choice Awards organised by the Association of Medical Media.
Pfizer Incl., manufacturer of the quit smoking drug chantix bagged a total of five awards which included one page and two page advertisements as well as highest ranked advertisements in the anti-infective and cardiovascular categories.